The global prostate cancer drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Increasing prevalence of prostate cancer, increased public awareness about prostate cancer treatment, improved research and development investments by drug founders, potent pipeline drugs, and the discovery of new treatments for advanced prostate cancer for the treatment […]
